Priveterra Acquisition Corp. II, operating as AEON Biopharma, Inc., reported its financial results for the third quarter ended September 30, 2026. The company reported cash and cash equivalents of $11.4 million as of September 30, 2026, which does not include approximately $6.2 m
On November 12, 2026, the board of directors of e.l.f. Beauty, Inc. appointed Amit Khetan, the Company’s Chief Accounting Officer, to serve as principal accounting officer of the Company. Mr. Khetan succeeds Mandy Fields, the Company’s Senior Vice President and Chief
On November 12, 2026, the Board of Directors of Jacobs Solutions Inc. increased the size of the Board from 9 to 10 authorized directors and elected Richard D. Phillips to fill the vacancy, effective December 1, 2026. Mr. Phillips will serve for an initial term that will expire at
STMicroelectronics N.V. announced that a broker acting for the Company repurchased 627,913 ordinary shares, equal to 0.07% of its issued share capital, on the regulated market of Euronext Paris. The transactions took place during the period between November 9, 2026 to November 13
On November 16, 2026, Dave Inc. announced that it has filed an application with the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation to establish Dave Bank, N.A., a proposed full-service national bank. In connection with the application, the
The wheat complex is showing mostly lower trade to start the week, as spring wheat is holding up. Chicago SRW futures are down 5 to 7 cents across most contracts at midday. KC HRW futures are down 9 to 11 cents so far. MPLS spring wheat are 1 ½ cents...
Diversified Healthcare Trust announced the posting of its November 2026 investor presentation, which outlines the company's strategic initiatives, updated financial guidance, and capital management plans. The company is updating its targeted leverage outlook to 5.5x - 6.5x, exclu
On November 16, 2026, Aytu BioPharma, Inc. announced that it has entered into a definitive merger agreement with Rosemont Pharmaceuticals Holdings, Inc., pursuant to which Rosemont would acquire Aytu through a cash tender offer for $2.70 per share, followed by a merger, represent
Sun Communities, Inc. released an investor presentation on November 16, 2026, detailing its updated financial guidance and operational outlook. The company projected 5.1% FY26E North America Same Property NOI Growth (Midpoint) – Increase of 0.2% and estimated $7.01 FY26E Co
Bed Bath & Beyond, Inc., which now operates as Neighborhood Intelligence, Inc., announced that its Board of Directors has authorized a share repurchase program on November 16, 2026. Under the program, the company may repurchase up to $25 million of its outstanding common stoc
Blue Dolphin Energy Company reported total gross profit of $26.5 million and net income of $18.9 million, or income of $1.27 per share, for the three months ended September 30, 2026. Comparatively, Blue Dolphin reported a total gross profit of less than $0.1 million and a net los
On November 16, 2026, Guardant Health, Inc. completed its private offering of $550 million aggregate principal amount of 0% Convertible Senior Notes due 2032, which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $50 million p
Research Solutions, Inc. reported financial results for its first quarter ended September 30, 2026. Total revenue was $11.9 million, compared to $12.3 million in the prior-year quarter. Platform subscription revenue for the quarter was $5.3 million, compared to $5.1 million in th
On November 16, 2026, Keros Therapeutics, Inc. announced that its board of directors has approved a new stock repurchase program for up to $5 million of the Company’s common stock. The authorization follows the receipt of a $20 million development milestone payment under th
On November 16, 2026, Cardlytics, Inc. announced a plan to reduce its workforce by approximately 30 full-time employees, representing approximately 15% of the Company’s current workforce. The plan is intended to optimize the Company’s cost structure and is part of a b
Acrivon Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, and highlighted the strategic expansion of its pipeline. The company established immunology and inflammation as a second strategic pillar, driven by the acquisition of ACR-52
FibroGen, Inc. (operating as Kyntra Bio, Inc.) reported its financial results for the third quarter of 2026 and announced several strategic updates. The company completed a restructuring of its royalty financing agreement with NQ Project Phoebus, L.P., which reduced the maximum a
The S&P 500 Index ($SPX ) (SPY ) closed down -1.92% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.67%. December E-mini S&P futures (ESZ26 ) fell -1.91%, and December E-mini Nasdaq futures...
Perfect Moment Ltd. announced that on November 15, 2026, Jane Gottschalk notified the Company of her resignation as a director of the Company and from her positions as the Company’s President and Creative Director. In connection with her resignation, on November 15, 2026, t
Treasure Global Inc. announced a 1-for-24 reverse stock split of its common stock, par value $0.00001 per share. The reverse stock split became effective as of 12:01 a.m. Eastern Time on November 16, 2026, and the common stock began trading on a split-adjusted basis when the Nasd